Navigation Links
Idenix to Host Conference Call Discussing First Quarter 2008 Financial Results

CAMBRIDGE, Mass., April 17 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc., (Nasdaq: IDIX) announced today that it will report its financial results for the first quarter of 2008 on Tuesday, April 29, 2008 before the U.S. financial markets open.

In conjunction with the issuance of the press release, Idenix management will host a conference call at 8:30 a.m. ET on Tuesday, April 29, 2008 to discuss the company's financial results for the first quarter 2008.

To access the call please dial 800-471-3635 U.S./Canada or 706-758-9475 International and provide conference identification number 43988689 or to listen to a live audio webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at A replay of the call will also be available from 11:30 a.m. ET on April 29, 2008 until 11:59 p.m. ET on May 13, 2008. To access the replay, please dial 800-642-1687 U.S./Canada or 706-645-9291 International and enter passcode 43988689. An archived webcast will also be available for two weeks after the call on the Idenix website.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by the hepatitis C virus and HIV. For further information about Idenix, please refer to

Idenix Pharmaceuticals' Contact:

Media: Teri Dahlman (617) 995-9905

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
2. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
3. Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
4. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
5. Idenix Pharmaceuticals to Present at the JP Morgan 26th Annual Healthcare Conference
6. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. CTG Announces 2008 First Quarter Conference Call and Webcast Information
9. APIC Conference to Address New CMS Regulations
10. APIC Conference to address new CMS regulations
11. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: